CHM chimeric therapeutics limited

its not underwritten but Bell Potter could scoop some up on...

  1. 5,630 Posts.
    lightbulb Created with Sketch. 9460
    its not underwritten but Bell Potter could scoop some up on behalf of their clients, or Paul Hopper may dip in for some more.

    But they have around $7.4m from Insto investors.. so they will get some more from retail and could do another raise early next year.. a bit earlier than they would have liked, but conditions may be better in 2023 with cohort 3 and cohort 4 of the CLTX trial reading out by then.. as well as other trials starting.

    So if they don't raise the $18.1m they are asking for at 0.17 cents.. and the next raise is higher than 17 cents (e.g. in early 2023).. then that would actually be a better outcome for shareholders and the company (albeit more work).
    Last edited by stockrock: 10/03/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $11.72K 2.783M

Buyers (Bids)

No. Vol. Price($)
4 2757364 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 15260220 25
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.